No. Description Packing UOM

Transcription

1 Republic of the Philippines PITC Pharma, Inc. Bids and Awards Committee INVITATION TO BID VARIOUS GENERIC & ONCOLOGY MEDICINES, MEDICAL DEVICE & SUPPLIES (PROJECT REF. NO. BAC/GOODS ) The PITC Pharma, Inc., through the Corporate Budget for Y2016, intends to apply the sum of Pesos: Seventeen Million Nine Hundred Forty Three Thousand Four Hundred Fifty Three (PhP17,943,453.00) being the Approved Budget for the Contract (ABC) to payments under the contract for the Procurement and Supply of Various Generic & Oncology Medicines, Medical Device & Supplies. Bids received in excess of the ABC shall be automatically rejected at bid opening. Various Generic Medicines Estimated Ceiling Price Quantity (in PhP) 1 Aciclovir 200mg tablet box of 100's tab 55, , Amlodipine (as besilate) 5mg tablet box of 100's tab 150, , Amoxicillin (as trihydrate) 500mg 3 capsule box of 100's cap 1,100, ,331, Ascorbic Acid 100mg/5mL syrup 60 ml bottle btl 5, , Ascorbic Acid 100mg/mL drops 15 ml bottle btl , Atenolol 50mg tablet box of 100's tab 68, , Captopril 25mg tablet box of 100's tab 116, , Carbamazepine 200mg tablet box of 100's tab 107, , Ceftriaxone (as disodium) 1g vial (IM, 9 IV) 1's vial , Cefuroxime (as axetil) 500mg tablet box of 100's tab 179, ,705, Cefuroxime (as sodium salt) 750mg 11 vial (IM, IV) 1's vial 1, , Cefuroxime 250mg/5mL 12 granules/powder for syrup/suspension 60 ml bottle btl , Cinnarizine 25 mg tablet box of 100's tab 70, , Ciprofloxacin (as hydrochloride) 500mg 14 tablet box of 100's tab 53, , Ciprofloxacin (as lactate) - WHO compliant 2mg/mL, 4mL vial (IV 15 infusion) 100mL vial vial , Ciprofloxacin (as lactate) 2mg/mL, 4mL 16 vial (IV infusion) 100mL vial vial , Clarithromycin 500mg tablet box of 100's tab 50, , Clindamycin (as hydrochloride) 300mg 18 capsule box of 100's cap 89, , Clindamycin (as phosphate) 150mg/mL 19 ampule (IM, IV) 4 ml amp 1, , Clopidogrel 75mg tablet box of 100's tab 53, ,382.00

2 No. Description Packing Co-Amoxiclav [amoxicillin (as trihydrate)+potassium clavulanate] 250 mg mg/5mL granules/powder for 21 suspension 60 ml bottle btl , Co-Amoxiclav [amoxicillin (as trihydrate)+potassium clavulanate] mg+125mg tablet box of 30's tab 55, , Cotrimoxazole (sulfamethoxazole + trimethoprim) 200mg+40mg/5mL 23 suspension 60mL bottle btl 4, , Dactinomycin powder 500mcg vial (IV) box of 1's vial , Dicycloverine (as hydrochloride) 25 10mg/5mL syrup 60 ml bottle btl 4, , Diphenhydramine (as hydrochloride) 26 50mg capsule box of 100's cap 150, , Doxycycline (as hyclate) 100mg 27 capsule box of 100's cap 150, , Enalapril (as maleate)10mg tablet box of 100's tab 130, , Felodipine 5mg tablet box of 100's tab 50, , Fluconazole 50mg capsule box of 30's cap 4, , Furosemide 40mg tablet box of 100's tab 14, , Fusidic Acid/Sodium 2% 32 Cream/Ointment 5g tube tube , Glibenclamide 5mg tablet box of 100's tab 550, , Imidazole (Ketoconazole) 2% Cream 15g tube tube , Lagundi (Vitex negundo L.) mg/5mL syrup 60 ml bottle btl 9, , Lagundi (Vitex negundo L.) 300mg 36 tablet box of 100's tab 300, , Lagundi (Vitex negundo L.) 600mg 37 tablet box of 60's tab 60, , Losartan + Hydrochlorothiazide 50mg mg tablet box of 100's tab 133, , Mefenamic Acid 250mg cap/tab box of 100's cap/tab 250, , Mefenamic Acid 500mg cap/tab box of 100's cap/tab 250, , Meropenem (as trihydrate) 1g powder box of 1's vial , Metronidazole 500mg tablet box of 100's tab 114, , Multivitamins per 5mL syrup 60 ml bottle btl 11, , Mupirocin 2% ointment 5g tube tube , Ofloxacin 400mg tablet box of 100's tab 125, , Paracetamol 500 mg tablet box of 100's tab 380, , Prednisone 5mg tablet box of 100's tab 110, , Ranitidine (as base and as 48 hydrochloride) 300mg tablet box of 100's tab 100, , Salbutamol (as sulfate) 1mg/mL ml nebule box of 30's neb 95, , Salbutamol (as sulfate) 200mcg/dose 50 dry powder capsule with inhaler 1 inhaler w/ 10 powder caps set , Salbutamol (as sulfate) 200mcg/dose 51 dry powder capsules box of 100's cap 200, , Salbutamol (as sulfate) 2mg tablet box of 100's tab 137, , ESTIMATED TOTAL BUDGET 10,524, UOM Estimated Quantity Ceiling Price (in PhP)

3 Oncology Medicines Estimated Quantity Ceiling Price (in Php) ABC (in Php) 1 Cyclophosphamide 500mg vial (IV) box of 1's vial 1, , Docetaxel (as anhydrous) 20mg/0.5mL vial (IV) box of 1's vial 1,250 1, ,346, Docetaxel (as anhydrous) 40mg/mL vial (IV) box of 1's vial 675 4, ,775, Doxorubicin (as hydrochloride) 50mg powder, vial (IV) box of 1's vial , Filgrastim (G-CSF) 300mcg/mL vial (IV, SC) box of 10's vial , Flourouracil 50mg/mL ampule or vial (IV, IV infusion) box of 10's amp/via l 1, , Ondansetron 2mg/mL, 4mL ampule (IM, IV) box of 5's amp 3, , Tamoxifen (as citrate) 20mg tablet box of 20's tab 2, , ESTIMATED TOTAL BUDGET 6,165, Medical Device and Supplies Estimated Ceiling Price Quantity (in PhP) 1 Glucometer Set box of 1's set , Lancet 25's pack , Nebulizer Set set , Test Strips (1µL blood sample 4 required) 25's pack , Test Strips (0.7µL blood sample 5 required) 25's pack , ESTIMATED TOTAL BUDGET 1,253, Cost of Bid Documents: Total ABC of items for bidding Cost of Bid Docs 500, and below , to 1.9M 1, M to 2.9M 2, M to 3.9M 3, M to 4.9M 4, M to 5.9M 5, M to 6.9M 6, M to 7.9M 7, M to 8.9M 8, M to 9.9M 9, M and above 10, Package: Total Generic Medicines 9, Total Oncology Medicines 5, Total Medical Device & Supplies

4 All particulars relative to eligibility, evaluation and award of contract shall be governed by the provisions of RA 9184, otherwise known as the Government Procurement Reform Act (GPRA) and its Implementing Rules and Regulations, as amended (IRR-A). Bidding will be conducted through open competitive bidding procedures using a non-discretionary pass/fail criterion. The PITC Pharma, Inc. through its Bids and Awards Committee (BAC) now invites manufacturers, suppliers/distributors/traders to apply for eligibility and to participate in the sealed competitive bidding for the above-mentioned project. Bidders should have ongoing and completed, within two (2) years from the date of submission and receipt of bids, at least two (2) contracts similar to the Project and whose value must be at least fifty percent (50%) of the ABC of the item to be bid. The description of an eligible bidder is contained in the Bidding Documents, particularly, in Section II. Instructions to Bidders. The PITC Pharma, Inc. reserves the right to accept or reject any bid, to annul the bidding process, to waive any required formality, to reject all bids at any time prior to contract award, without thereby incurring any liability to the affected bidder or bidders and to award the contract to the bidder whose proposal has been evaluated by the BAC as the most advantageous to PITC Pharma, Inc. and the right to confiscate the bid and/or pursue appropriate legal action should the winning bidder refuse to accept the award. MINIMUM REQUIREMENTS FOR BIDDERS: In the Pharmaceutical business for at least two (2) years and still in operation. With stockholders equity or capital account of at least PhP2 Million as of December 31, 2014 or its equivalent in US Dollars (US$). Must have a valid Certificate of Good Manufacturing Practice (CGMP) in line with the WHO/PIC/S certification scheme on pharmaceuticals moving in International Commerce from the regulatory authority (RA) in the country of manufacture of the goods and duly authenticated by the appropriate Philippine Embassy/Consulate in country where business is based. The schedule of activities is listed as follows: Activity Availability of Bid Documents Pre-Bid Conference Deadline for Submission of Bids Opening of Bids Date/Place February12 to March 01, 2016 BAC Secretariat Office, 2/F NDC Building, 116 February 19, 2016 ; 10am 2/F Conference Room, NDC Building, 116 March 02, 2016 ; 9:30am BAC Secretariat Office, 2/F NDC Building, 116 March 02, 2016, 10:00am 2/F Conference Room, NDC Building, 116 Complete set of bid documents may be purchased from the BAC Secretariat Office at the address stated above and upon payment of the corresponding nonrefundable cost of bid documents.

5 Further, PITC Pharma, Inc. assumes no obligations whatsoever to compensate or indemnify the bidder/s for any expense or loss that they may incur in this undertaking nor does it guarantee that an award will be made. For further information, please contact the following: Irma C. Lim Head, BAC Secretariat Tel. No Posting on P-GEPS, PPI Website and Conspicuous place on February12, 2016 Published on Philippine Star on February12, 2016 (sgd) JOSE A. CORTEZ BAC Chairman.